Checkpoint Therapeutics wins FDA nod for skin cancer therapy

Sedang Trending 1 bulan yang lalu
  • Healthcare
Hand holding a insubstantial FDA APPROVED connected greenish background

Yaraslau Butkevich

  • The U.S. Food and Drug Administration (FDA) has approved Checkpoint Therapeutics’ (NASDAQ:CKPT) PD-L1 blocking antibody Unloxcyt cosibelimab-ipdl arsenic a curen for definite patients pinch tegument cancer, cutaneous squamous compartment carcinoma (cSCC).
  • Accordingly, nan intravenous infusion will beryllium disposable arsenic a late-line

Recommended For You

More Trending News

See More »

Selengkapnya
Sumber 1
1